IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Acta Pharmacologica Sinica

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on September 3, 2024

Impact Score

2023-2024

7.19

h-Index

2023-2024

 117

Rank

2023-2024

 1505

SJR

2023-2024

 1.882

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Acta Pharmacologica Sinica
Abbreviation Acta Pharmacol. Sin.
Publication Type Journal
Subject Area, Categories, Scope Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)
h-index 117
Overall Rank/Ranking 1505
SCImago Journal Rank (SJR) 1.882
Impact Score 7.19
Publisher Nature Publishing Group
Country United Kingdom
ISSN 16714083, 17457254
Best Quartile Q1
Coverage History 1980-2023




Aim and Scope


APS, China"s leading journal in pharmacology, encourages submissions from all areas of pharmacology and the life sciences. Topics of particular interest include, but are not limited to, anticancer pharmacology, cardiovascular and pulmonary pharmacology, clinical pharmacology, drug discovery, gastrointestinal and hepatic pharmacology, genitourinary, renal and endocrine pharmacology, immunopharmacology and inflammation, molecular and cellular pharmacology, neuropharmacology, pharmaceutics and pharmacokinetics.


About Acta Pharmacologica Sinica


Acta Pharmacologica Sinica is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1). It is published by Nature Publishing Group. The overall rank of Acta Pharmacologica Sinica is 1505. According to SCImago Journal Rank (SJR), this journal is ranked 1.882. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 117. The best quartile for this journal is Q1.

The ISSN of Acta Pharmacologica Sinica journal is 16714083, 17457254. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Acta Pharmacologica Sinica is cited by a total of 5055 articles during the last 3 years (Preceding 2023).


Acta Pharmacologica Sinica Impact IF 2023-2024


The Impact IF 2023 of Acta Pharmacologica Sinica is 7.19, which is computed in 2024 as per its definition. Acta Pharmacologica Sinica IF is decreased by a factor of 2.02 and approximate percentage change is -21.93% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Acta Pharmacologica Sinica Impact IF 2024 Prediction


Impact IF 2023 of Acta Pharmacologica Sinica is 7.19. If the same downward trend persists, Impact IF may fall in 2024 as well.


Impact IF Trend


Year wise Impact IF of Acta Pharmacologica Sinica. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2023 7.19
2022 9.21
2021 7.10
2020 5.09
2019 4.59
2018 3.80
2017 3.42
2016 3.00
2015 3.11
2014 2.66

Acta Pharmacologica Sinica h-index


  Table Setting

Acta Pharmacologica Sinica has an h-index of 117. It means 117 articles of this journal have more than 117 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Acta Pharmacologica Sinica ISSN


The ISSN of Acta Pharmacologica Sinica is 16714083, 17457254. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Acta Pharmacologica Sinica Rank and SCImago Journal Rank (SJR)


The overall rank of Acta Pharmacologica Sinica is 1505. According to SCImago Journal Rank (SJR), this journal is ranked 1.882. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Acta Pharmacologica Sinica by Year


Year SJR
2023/2024 Coming Soon
2023 1.882
2022 1.677
2021 1.472
2020 1.514
2019 1.195
2018 1.224
2017 1.173
2016 1.250
2015 1.136
2014 1.054

Ranking of Acta Pharmacologica Sinica by Year


Year Ranking
2023/2024 Coming Soon
2023 1505
2022 1762
2021 2156
2020 2242
2019 3270
2018 3218
2017 3437
2016 3136
2015 3703
2014 4013

Acta Pharmacologica Sinica Publisher


Table Setting

Acta Pharmacologica Sinica is published by Nature Publishing Group. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1980-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Acta Pharmacologica Sinica is Acta Pharmacol. Sin.. This abbreviation ('Acta Pharmacol. Sin.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Acta Pharmacologica Sinica


If your research field is/are related to Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Acta Pharmacologica Sinica?

Acta Pharmacologica Sinica latest impact IF is 7.19. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 9.21 (2022) and 2.66 (2014), respectively, in the last 10 years. Moreover, its average IS is 4.92 in the previous 10 years.


What's the SCImago Journal Rank (SJR) of the Acta Pharmacologica Sinica?

The Acta Pharmacologica Sinica has an SJR (SCImago Journal Rank) of 1.882, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.882 in 2023 and the lowest being 1.054 in 2014. Furthermore, the average SJR of the Acta Pharmacologica Sinica over the previous 10-year period stands at 4.92.


What's the latest h-index of the Acta Pharmacologica Sinica?

The latest h-index of the Acta Pharmacologica Sinica is 117.


Who's the publisher of the Acta Pharmacologica Sinica?

The Acta Pharmacologica Sinica is published by the Nature Publishing Group, with its country of publication being the United Kingdom.


What's the current ranking of the Acta Pharmacologica Sinica?

The Acta Pharmacologica Sinica is currently ranked 1505 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 1505 in 2023 and its lowest position of 4013 in 2014.


What's the abbreviation or short name for the Acta Pharmacologica Sinica?

The standard ISO4 abbreviation for the Acta Pharmacologica Sinica is Acta Pharmacol. Sin..


Is the "Acta Pharmacologica Sinica" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Acta Pharmacologica Sinica is classified as a journal that the Nature Publishing Group publishes.


What's the scope or major areas of the Acta Pharmacologica Sinica?

The Acta Pharmacologica Sinica encompasses the following areas:

  • Medicine (miscellaneous)
  • Pharmacology
  • Pharmacology (medical)

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Acta Pharmacologica Sinica?

The Acta Pharmacologica Sinica is assigned the following International Standard Serial Numbers (ISSN): 16714083, 17457254.


What's the best quartile of the Acta Pharmacologica Sinica?

The best quartile for the Acta Pharmacologica Sinica is Q1 (2023).


What's the coverage history of the Acta Pharmacologica Sinica?

The Acta Pharmacologica Sinica coverage history can be summarized as follows: 1980-2023.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Academic Ethics journal 10291 Springer Netherlands 30 2.62
Analysis in Theory and Applications journal 19346 Springer Netherlands 11 0.00
Current Sociology journal 7193 SAGE Publications Ltd 80 2.46
Milan Journal of Mathematics journal 3538 Birkhauser Verlag Basel 29 1.14
International Journal of Mathematical Education in Science and Technology journal 8417 Taylor and Francis Ltd. 42 1.17
Air and Space Power Journal (discontinued) journal 28397 AU Press 9 0.20
Journal of Classical Sociology journal 15798 SAGE Publications Ltd 30 1.30
Howard Journal of Communications journal 10151 Taylor and Francis Ltd. 39 1.66
Tekstilec trade journal 18966 University of Ljubljana Press 15 0.91
Exploration Geophysics journal 13768 Taylor and Francis Ltd. 50 1.06

Check complete list




Year wise Impact Score (IS) of Acta Pharmacologica Sinica

Impact Score Table

Year Impact Score (IS)
2024/2025 Coming Soon
2023 7.19
2022 9.21
2021 7.10
2020 5.09
2019 4.59
2018 3.80
2017 3.42
2016 3.00
2015 3.11
2014 2.66



Top Journals/Conferences in Medicine (miscellaneous)

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Research | United Kingdom

Current Protocols in Bioinformatics
John Wiley & Sons Inc. | United States

MMWR supplements
Epidemiology Program Office | United States

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Annals of Oncology
Elsevier Ltd | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Nature Reviews Methods Primers
Springer Nature | United States

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Drug Resistance Updates
Churchill Livingstone | United States

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Trends in Pharmacological Sciences
Elsevier Ltd | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Acta Pharmaceutica Sinica B
Chinese Academy of Medical Sciences | China

Theranostics
Ivyspring International Publisher | Australia

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Elsevier B.V. | Netherlands

Journal of Biomedical Science
BioMed Central Ltd | United Kingdom

Drugs
Adis International Ltd | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Clinical Pharmacology and Therapeutics
Wiley-Blackwell | United States

BioDrugs
Adis International Ltd | United Kingdom

See All